Stockscreener 앱 받기
10.46
2.79%
-0.30
시간 외 거래:
10.46
Maplight Therapeutics Inc 주식(MPLT)의 최신 뉴스
MapLight stock falls 46% as InvestingPro Fair Value flagged overvaluation By Investing.com - Investing.com
MPLT Stock Plunges 73% — Wipes Out Over $1B In Market Cap After Trial Miss On Once-Daily Dose - Stocktwits
MapLight Therapeutics, Inc.(NasdaqGS:MPLT) dropped from S&P Biotechnology Select Industry Index - marketscreener.com
IPO Databook: MapLight Therapeutics (MPLT US)Sep 2026 - Smartkarma
MapLight Therapeutics (MPLT) General Counsel Kristopher Hanson Sells 16,509 Shares - gurufocus.com
Maplight Therapeutics, Inc. (NASDAQ:MPLT) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
MapLight Therapeutics (MPLT) exec to sell shares under preset trading plan - Stock Titan
MapLight Therapeutics (MPLT) Edges Lower to $11.85, Testing Support Near $11.26Long Term Entry Picks - dars.gov.et
Maplight Therapeutics (NASDAQ:MPLT) Stock Price Down 7.8%Here's Why - MarketBeat
MapLight Therapeutics, Inc. (MPLT) Stock Price Quote Today & Current Price Chart - Capital.com
MapLight Therapeutics to Participate in Upcoming Investor Conference - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against MapLight Therapeutics, Inc. (MPLT) and Encourages Stockholders to Learn More About the Investigation - accessnewswire.com
Raymond James initiates coverage on MapLight Therapeutics with Strong Buy - scanx.trade
BlackRock Inc. Takes $36.74 Million Position in Maplight Therapeutics, Inc. $MPLT - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Trading Up 5.3%Here's What Happened - MarketBeat
Needham cuts MapLight Therapeutics price target on dilution concerns By Investing.com - Investing.com Canada
Maplight Therapeutics (NASDAQ:MPLT) Price Target Lowered to $43.00 at Needham & Company LLC - MarketBeat
MapLight Therapeutics (MPLT) Edges Higher to $12.60 as Traders Eye Key Resistance at $13.23PCR Moving Average - careplusvn.com
Freestone Grove Partners LP Makes New $6.05 Million Investment in Maplight Therapeutics, Inc. $MPLT - MarketBeat
5AM Venture Management LLC Makes New Investment in Maplight Therapeutics, Inc. $MPLT - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Trading Down 4.6%What's Next? - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Trading 7.8% HigherShould You Buy? - MarketBeat
Maplight Therapeutics, Inc. (NASDAQ:MPLT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Segal Trials Reinforces Leadership in Acute Schizophrenia Research Following Participation in MapLight Therapeutics’ Phase 2 ZEPHYR Study - Business Wire
Blue Owl Capital Holdings LP Takes $26.16 Million Position in Maplight Therapeutics, Inc. $MPLT - MarketBeat
MPLT: MapLight Therapeutics, Inc.Financial Overview - Zacks Investment Research
MapLight Therapeutics (MPLT): Nan Fung group holds passive stake above 5% - Stock Titan
Maplight Therapeutics (NASDAQ:MPLT) Stock Price Down 7%Should You Sell? - MarketBeat
MapLight Therapeutics (MPLT) grants CDO 24K options and 6K RSUs - Stock Titan
MapLight (NASDAQ: MPLT) grants CEO 93,955 options and 23,145 RSUs - Stock Titan
MapLight Therapeutics (MPLT) grants CSO new options and RSUs - Stock Titan
MapLight (MPLT) Reported Results Review: The EPS Result Is Below Expectation in the Reported Period; Trading-Day Reaction: Shares Rise 5.11% in Latest TradingGuidance Downgrade Alert - Vinanet
Catalyst4 builds 49.9% MapLight (MPLT) stake in private share deal - Stock Titan
MPLT Q1 2026 Earnings: Clinical-Stage Biotech Reports Wider-Than-Expected Loss of -$1.34 Per ShareROE Trend Analysis - careplusvn.com
MapLight Therapeutics, Inc. (MPLT) - Zacks Investment Research
MapLight Therapeutics announces $150M private placement - TipRanks
Morgan Stanley Maintains MapLight Therapeutics(MPLT.US) With Hold Rating, Maintains Target Price $21 - Moomoo
Maplight Therapeutics (NASDAQ:MPLT) Stock Rating Upgraded by Wall Street Zen - MarketBeat
LifeSci Capital Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Maintains Target Price $37 - Moomoo
BMO Capital Initiates MapLight Therapeutics(MPLT.US) With Buy Rating, Announces Target Price $20 - Moomoo
MapLight presses the pause button; ADC Therapeutics considers what to do with Zynlonta - Endpoints News
MapLight Therapeutics Announces $150 Million Private Placement Financing - marketscreener.com
MapLight bags USD 150m after muscarinic schizophrenia Phase II win - AllSci
MapLight Therapeutics, Inc. Stock 12‑Month Price Target Cut to $28.77, Implies 148% Upside - TradingView
Dividend HistoryMapLight Therapeutics, Inc. (MPLT) - Zacks Investment Research
MapLight Reports Positive Phase 2 Schizophrenia Data, Plans Phase 3 Trial - Minichart
Needham raises MapLight Therapeutics price target to $45 - scanx.trade
MapLight Q2 Results: Net loss widens to $60.2M, cash runway extends to 2028 - scanx.trade
MapLight Therapeutics Secures $150 Million Through Private Stock Placement - Kalkine Media
MapLight Therapeutics Announces Q2 2026 Financial Results with Rising Losses and R&D Expenses - Kalkine Media
Form 8K MapLight Therapeutics Inc For: 13 August By Investing.com - Investing.com Nigeria
MapLight Therapeutics (Nasdaq: MPLT) boosts cash with $150M private deal - Stock Titan
MapLight Therapeutics 2Q 2026: Net loss $60.2M, EPS $(1.32) — 10-Q Summary - TradingView
MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Maplight Therapeutics (NASDAQ:MPLT) Trading Up 6.4%Here's Why - MarketBeat
Latham Advises on MapLight Therapeutics’ US$150 Million Private Placement Financing - Latham & Watkins LLP
MapLight Therapeutics secures $150 million financing - The Pharma Letter
MapLight Therapeutics stock jumps on $150M private placement By Investing.com - Investing.com Nigeria
Why is MapLight Therapeutics stock rallying today? - Investing.com
MapLight Therapeutics raises $150 million in private placement - Investing.com
Why is MapLight Therapeutics stock rallying today? By Investing.com - Investing.com South Africa
Zealand’s royalty deal; Khartis raises money for TED drug - Endpoints News
3.06%
2.55%
자본화:
|
볼륨(24시간):